Company Filing History:
Years Active: 2024
Title: The Innovations of Shung Wu
Introduction
Shung Wu is an accomplished inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. His work focuses on addressing diseases mediated by Janus kinases, which are crucial in various inflammatory and autoimmune conditions.
Latest Patents
Shung Wu holds a patent for "Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof." This patent includes substituted imidazo[1,2-a]pyridin-2-ylamine compounds, exemplified by formula (A), and outlines pharmaceutical compositions derived from these compounds. The methods described in the patent aim to treat, prevent, or ameliorate symptoms associated with Janus kinase-mediated diseases. He has 1 patent to his name.
Career Highlights
Wu is currently associated with Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd., where he continues to innovate and develop new therapeutic solutions. His expertise in medicinal chemistry and drug development has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
One of his notable collaborators is Jin Li, with whom he has worked on various projects aimed at advancing pharmaceutical research and development.
Conclusion
Shung Wu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to pave the way for new treatments that can significantly impact patient care.